Effect on the Production of Soluble Endoglin from Human Choriocarcinoma Cells by Preeclampsia Sera

American Journal of Reproductive Immunology

Volumn 67, Issue 5, 2012, Pages 413-420

  Aoki, Youichi ^a   Yamamoto, Tatsuo ^a   Fumihisa, Chishima ^a   Nakamura, Akikazu ^a   Asanuma, Aki ^a   Suzuki, Manami ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Choriocarcinoma cell; Endoglin; Preeclampsia; Serum factor; Trophoblast

Indexed keywords

ENDOGLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; MESSENGER RNA; PROTOPORPHYRIN ZINC; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER CELL CULTURE; CARCINOMA CELL; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TROPHOBLAST;

ADULT; ANTIGENS, CD; CELL LINE, TUMOR; CHORIOCARCINOMA; FEMALE; HEME OXYGENASE-1; HUMANS; IMMUNOGLOBULIN G; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 84859699761     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01086.x     Document Type: Article

References (27)

1. Cheifetz S, Bellón T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M: Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992; 267:19027-19030.
2. Gougos A, St Jacques S, Greaves A, O'Connell PJ, d'Apice AJ, Bühring HJ, Bernabeu C, van Mourik JA, Letarte M: Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 1992; 4:83-92.
3. Inoue N, Venema RC, Sayegh HS, Ohara Y, Murphy TJ, Harrison DG: Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol 1995; 15:1255-1261.
4. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642-649.
5. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M: A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005; 96:684-692.
6. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672-683.
7. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y: Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 2008; 14:855-862. Epub 2008 Jul 27.
8. Zhu Y, Sun Y, Xie L, Jin K, Sheibani N, Greenberg DA: Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells. Stroke 2003; 34:2483-2488. Epub 2003 Aug 28.
9. Munaut C, Lorquet S, Pequeux C, Blacher S, Berndt S, Frankenne F, Foidart JM: Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum Reprod 2008;23: 1407-1415. Epub 2008 Apr 14.
10. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A: Negative regulation of soluble FLT-1 and Soluble Endoglin Release by Hemo Oxygenase-1. Circulation 2007; 115:1789-1797.
11. Kalkunte S, Boij R, Norris W, Friedman J, Lai Z, Kurtis J, Lim KH, Padbury JF, Matthiesen L, Sharma S: Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am J Pathol 2010; 177:2387-2398. Epub 2010 Oct 1.
12. Yu D, Zhuang L, Sun X, Chen J, Yao Y, Meng K, Ding Y: Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma. BMC Cancer 2007; 7:122.
13. Smith G, Dawe RS, Clark C, Evans AT, Comrie MM, Wolf CR, Ferguson J, Ibbotson SH: Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation. J Invest Dermatol 2003; 121:390-398.
14. Velasco-Loyden G, Arribas J, Lopez-Casillas F: The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. J Biol Chem 2004; 279:7721-7733.
15. Henry-Berger J, Mouzat K, Baron S, Bernabeu C, Marceau G, Saru JP, Sapin V, Lobaccaro JM, Caira F: Endoglin (CD105) expression is regulated by the liver X receptor alpha (NR1H3) in human trophoblast cell line JAR. Biol Reprod 2008; 78:968-975. Epub 2008 Feb 14.
16. Yamamoto T, Takahashi Y, Geshi Y, Sasamori Y, Mori H: Anti-phospholipid antibodies in preeclampsia and their binding ability for placental villous lipid fractions. J Obstet Gynaecol Res 1996; 22:275-283.
17. Yamamoto T, Takahashi Y, Kuno S, Geshi Y, Sasamori Y, Mori H: Effects of anti-endothelial cell antibody in pre-eclampsia on endothelin-1 release from cultured endothelial cells. Immunol Cell Biol 1997; 75:340-344.
18. Tenhunen R, Marver HS, Schmid R: Microsomal heme oxygenase: characterization of the enzyme. J Biol Chem 1969; 244:6388-6394.
19. Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I, Bussolati B, St John J: Induction of placental heme oxygenase-1 is protective against TNF alpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 2000; 6:391-409.
20. Barber A, Robson SC, Myatt L, Bulmer JN, Lyall F: Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction. FASEB J 2001; 15:1158-1168.
21. Baum M, Schiff E, Kreiser D, Dennery PA, Stevenson DK, Rosenthal T, Seidman DS: End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol 2000; 183:900-903.
22. Kreiser D, Baum M, Seidman DS, Fanaroff A, Shah D, Hendler I, Stevenson DK, Schiff E, Druzin ML: End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia. J Perinatol 2004; 24:213-217.
23. Gilbert JS, Gilbert SA, Arany M, Granger JP: Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 2009; 53:399-403.
24. Nowis D, Bugajski M, Winiarska M, Bil J, Szokalska A, Salwa P, Issat T, Was H, Jozkowicz A, Dulak J, Stoklosa T, Golab J: Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice. BMC Cancer 2008; 8:197.
25. Saito S, Sakai M, Sasaki Y, Tanabe K, Tsuda H, Michimata T: Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117:550-555.
26. Jonsson Y, Rubèr M, Matthiesen L, Berg G, Nieminen K, Sharma S, Ernerudh J, Ekerfelt C: Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70:83-91. Epub 2006 Jan 18.
27. Munno I, Chiechi LM, Lacedra G, Berardesca C, Patimo C, Marcuccio L, Nardelli P, Loizzi P: Evaluation of nonspecific immunity and plasma levels of interferon-gamma, interleukin-6 and tumor necrosis factor-alpha in preeclampsia. Immunopharmacol Immunotoxicol 1999; 21:551-564.